Jefferies Group LLC lifted its stake in shares of PerkinElmer, Inc. (NYSE:PKI) by 464.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,586 shares of the medical research company’s stock after purchasing an additional 21,053 shares during the quarter. Jefferies Group LLC’s holdings in PerkinElmer were worth $1,871,000 at the end of the most recent quarter.
Several other institutional investors also recently added to or reduced their stakes in the company. BlackRock Inc. raised its stake in shares of PerkinElmer by 3.2% during the fourth quarter. BlackRock Inc. now owns 6,260,111 shares of the medical research company’s stock worth $457,740,000 after purchasing an additional 195,851 shares during the last quarter. King Luther Capital Management Corp raised its stake in shares of PerkinElmer by 1.3% during the third quarter. King Luther Capital Management Corp now owns 2,562,833 shares of the medical research company’s stock worth $176,759,000 after purchasing an additional 32,248 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of PerkinElmer by 5.9% during the fourth quarter. Geode Capital Management LLC now owns 1,263,958 shares of the medical research company’s stock worth $92,282,000 after purchasing an additional 70,219 shares during the last quarter. Bank of New York Mellon Corp raised its stake in shares of PerkinElmer by 8.0% during the fourth quarter. Bank of New York Mellon Corp now owns 1,007,210 shares of the medical research company’s stock worth $73,647,000 after purchasing an additional 74,735 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its stake in shares of PerkinElmer by 9.9% during the third quarter. Ameriprise Financial Inc. now owns 955,790 shares of the medical research company’s stock worth $65,923,000 after purchasing an additional 86,395 shares during the last quarter. Institutional investors and hedge funds own 91.94% of the company’s stock.
Shares of PerkinElmer, Inc. (NYSE PKI) opened at $78.08 on Wednesday. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.26 and a quick ratio of 0.89. The firm has a market capitalization of $8,705.53, a price-to-earnings ratio of 26.98, a price-to-earnings-growth ratio of 1.82 and a beta of 0.79. PerkinElmer, Inc. has a twelve month low of $55.41 and a twelve month high of $84.49.
The company also recently announced a quarterly dividend, which will be paid on Thursday, May 10th. Shareholders of record on Friday, April 13th will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 0.36%. The ex-dividend date is Thursday, April 12th. PerkinElmer’s dividend payout ratio (DPR) is 10.61%.
Several equities research analysts have recently commented on PKI shares. Bank of America upgraded PerkinElmer from an “underperform” rating to a “neutral” rating and set a $78.00 price target for the company in a research note on Tuesday, December 19th. Evercore ISI assumed coverage on PerkinElmer in a research report on Wednesday, January 3rd. They issued an “in-line” rating and a $77.00 price objective for the company. Zacks Investment Research upgraded PerkinElmer from a “hold” rating to a “buy” rating and set a $86.00 price objective for the company in a research report on Monday, January 8th. Cowen reiterated a “hold” rating and issued a $84.00 price objective on shares of PerkinElmer in a research report on Friday, January 26th. Finally, ValuEngine cut PerkinElmer from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and six have assigned a buy rating to the stock. PerkinElmer has a consensus rating of “Hold” and a consensus price target of $76.85.
In other PerkinElmer news, insider Andrew Okun sold 2,273 shares of the company’s stock in a transaction on Monday, February 5th. The stock was sold at an average price of $77.86, for a total value of $176,975.78. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Frank Anders Wilson sold 103,656 shares of the stock in a transaction on Monday, March 5th. The shares were sold at an average price of $73.94, for a total value of $7,664,324.64. Following the sale, the insider now directly owns 93,624 shares in the company, valued at approximately $6,922,558.56. The disclosure for this sale can be found here. Insiders sold 120,933 shares of company stock worth $8,929,583 in the last three months. 2.20% of the stock is owned by corporate insiders.
ILLEGAL ACTIVITY NOTICE: “Jefferies Group LLC Has $1.87 Million Stake in PerkinElmer, Inc. (PKI)” was first published by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another site, it was illegally copied and republished in violation of international copyright and trademark laws. The correct version of this piece can be read at https://www.tickerreport.com/banking-finance/3261705/jefferies-group-llc-has-1-87-million-stake-in-perkinelmer-inc-pki.html.
PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.
Want to see what other hedge funds are holding PKI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PerkinElmer, Inc. (NYSE:PKI).
Receive News & Ratings for PerkinElmer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer and related companies with MarketBeat.com's FREE daily email newsletter.